Cancer/Tumor Profiling Market by Technology, by Technique, by Application, by Geography - Global Market Size, Share, Development, Growth and Demand Forecast, 2013-2023

  • ID: 4451372
  • Report
  • Region: Global
  • 161 pages
  • P&S Market Research
1 of 4
Global Cancer/Tumor Profiling Market Size is Projected to Achieve a Value of $87.1 Billion Value By 2023, Growing at a CAGR of 19.0% During 2017-2023.

FEATURED COMPANIES

  • Caris Life Sciences, Inc.
  • Genomic Health, Inc.
  • Helomics Corp.
  • Illumina, Inc.
  • NeoGenomics Inc.
  • Oxford Gene Technology
  • MORE

Cancer/Tumor Profiling Market by Technology (Next Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (QPCR), Immunohistochemistry (IHC), In-situ Hybridization (ISH), Microarray), by Technique (Genomics, Proteomics, Epigenetics, Metabolomics), by Application (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics), by Geography (U.S., Canada, Germany, U.K., France, Japan, China, Brazil, Mexico) - Global Market Size, Share, Development, Growth and Demand Forecast, 2013-2023

The boost in demand for cancer/tumor profiling products is mainly led by increasing number of new cancer cases, rising utility of biomarkers in tumor profiling, rising availability of funding for cancer research and increasing demand for next generation sequencing for cancer profiling.

Insights on market segments

The cancer profiling market has been bifurcated into next generation sequencing (NGS), quantitative polymerase chain reaction (QPCR), immunohistochemistry (IHC), in-situ hybridization (ISH), and microarray, based on technology. NGS held the largest share in the cancer profiling market, standing at 33.1%, in 2016. This leading position of NGS is mainly characterized by increased awareness about NGS products due to rising promotional activities for these products among the research laboratories and academic institutes. The NGS category is also expected to grow at the highest CAGR during the forecast period.

ISH is further categorized into fluorescent in situ hybridization (FISH) and chromogenic in situ hybridization (CISH). FISH held the larger share of the ISH technology market in 2016. The higher penetration of this technology is driven by increasing number of players offering FISH in cancer profiling market, such as Abbott Laboratories. FISH is also expected to observe the faster growth in future, with the CAGR likely to stand at 18.6% during the forecast period.

The various techniques used in the cancer profiling include genomics, proteomics, epigenetics, and metabolomics. Genomics held the largest share of 40.6% in 2016, and it is also expected to register highest growth during the forecast period, due to increasing implementation of genomic sequencing.

Cancer profiling is used in varied applications such as personalized medicine, diagnostics, biomarker discovery, prognostics, and others. In 2016, personalized medicine held largest share of 36.4% in the cancer profiling market, attributed to subsequent increasing adoption of personalized medicine for tumor profiling, since it is one of the most cost-effective methods. The application is also expected to register fastest growth during the forecast period.

Asia-Pacific is projected to register the fastest growth in cancer/tumor profiling market

The Asia-Pacific cancer profiling market has been experiencing significant growth due to rising prevalence of cancer, increasing government initiatives for cancer treatment, and rising healthcare expenditure in the region. According to the Indian Council of Medical Research (ICMR), around 14.5 lakhs of new cancer cases were registered in India in 2016, which is likely to reach nearly 17.3 lakh new cases, by 2020. This increase in cancer cases indicates that, the healthcare providers will require more profiling kits, thus increasing the demand for cancer/tumor profiling kits in the region.

Key competitors are introducing new and innovative products cancer/tumor profiling market

Globally, the key providers in the cancer profiling market are launching new products to gain a larger market share. In October 2017, QIAGEN N.V. launched custom solutions business, aimed at providing life sciences and molecular diagnostics companies with the tools and expertise required to quickly build and commercialize products that meet unique workflow requirements. In the same month, the company also launched ipsogen JAK2 RGQ PCR kit, an ipsogen JAK2 assay, an assay used for the detection of the JAK2 V617F/G1849T allele in genomic DNA extracted from EDTA whole blood.

Some of the other key players operating in the cancer profiling market include Illumina, Inc., NeoGenomics Inc., Caris Life Sciences, Inc., Helomics Corp., Oxford Gene Technology, HTG Molecular Diagnostics, Inc., RiboMed Biotechnologies, Inc., Genomic Health, Inc., and NanoString Technologies, Inc.

READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Caris Life Sciences, Inc.
  • Genomic Health, Inc.
  • Helomics Corp.
  • Illumina, Inc.
  • NeoGenomics Inc.
  • Oxford Gene Technology
  • MORE
Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation by Technology
1.3.2 Market Segmentation by Technique
1.3.3 Market Segmentation by Application
1.3.4 Market Segmentation by Geography
1.3.5 Analysis Period
1.3.6 Market Data Reporting Unit
1.3.6.1 Value
1.4 Key Stakeholders

Chapter 2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.2.1 Breakdown of Primary Research Respondents
2.2.1.1 By region
2.2.1.2 By industry participant
2.2.1.3 By company type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Technology
4.1.1.1 NGS
4.1.1.2 QPCR
4.1.1.3 IHC
4.1.1.4 ISH
4.1.1.4.1 FISH
4.1.1.4.2 CISH
4.1.1.5 Microarray
4.1.2 By Technique
4.1.2.1 Genomics
4.1.2.2 Proteomics
4.1.2.3 Epigenetics
4.1.2.4 Metabolomics
4.1.3 By Application
4.1.3.1 Personalized medicine
4.1.3.2 Diagnostics
4.1.3.3 Biomarker discovery
4.1.3.4 Prognostics
4.1.3.5 Others
4.2 Market Dynamics
4.2.1 Drivers
4.2.1.1 Increasing number of new cancer cases
4.2.1.2 Rising utility of biomarkers in tumor profiling
4.2.1.3 Rise in availability of funding for cancer research
4.2.1.4 Increasing demand for next generation sequencing for cancer profiling
4.2.1.5 Impact analysis of drivers on market forecast
4.2.2 Restraints
4.2.2.1 High capital investments and low benefit ratio for biomarkers
4.2.2.2 Dearth of skilled professionals and infrastructure
4.2.2.3 Impact analysis of restraints on market forecast
4.2.3 Opportunities
4.2.3.1 Increasing use of point-of-care diagnostic tests
4.2.3.2 Rising demand for personalized medicine
4.3 Porter’s Five Forces Analysis
4.3.1 Bargaining Power of Buyers
4.3.2 Bargaining Power of Suppliers
4.3.3 Intensity of Rivalry
4.3.4 Threat of New Entrants
4.3.5 Threat of Substitutes

Chapter 5. Global Market Size and Forecast
5.1 By Technology
5.1.1 ISH Technology by Type
5.2 By Technique
5.3 By Application
5.4 By Region

Chapter 6. North America Market Size and Forecast
6.1 By Technology
6.2 By Technique
6.3 By Application
6.4 By Country

Chapter 7. Europe Market Size and Forecast
7.1 By Technology
7.2 By Technique
7.3 By Application
7.4 By Country

Chapter 8. Asia-Pacific Market Size and Forecast
8.1 By Technology
8.2 By Technique
8.3 By Application
8.4 By Country

Chapter 9. LATAM Market Size and Forecast
9.1 By Technology
9.2 By Technique
9.3 By Application
9.4 By Country

Chapter 10. MEA Market Size and Forecast
10.1 By Technology
10.2 By Technique
10.3 By Application

Chapter 11. Global Market Size and Forecast by Technology
11.1 Global NGS Market, by Region
11.2 Global QPCR Market, by Region
11.3 Global IHC Devices Market, by Region
11.4 Global ISH Market, by Region
11.5 Global Microarray Market, by Region

Chapter 12. Global Market Size and Forecast by Technique
12.1 Global Genomics Market, by Region
12.2 Global Proteomics Market, by Region
12.3 Global Epigenetics Devices Market, by Region
12.4 Global Metabolomics Market, by Region

Chapter 13. Global Market Size and Forecast by Application
13.1 Global Personalized Medicine Market, by Region
13.2 Global Diagnostics Market, by Region
13.3 Global Biomarker Discovery Market, by Region
13.4 Global Prognostics Market, by Region

Chapter 14. Competitive Landscape
14.1 Product Benchmarking of Key Players
14.2 Global Strategic Developments of Key Players
14.2.1 Product Launches and Approvals
14.2.2 Agreements, Partnerships and Collaborations
14.2.3 Facility Expansion
14.2.4 Other Developments

Chapter 15. Company Profiles
15.1 Illumina, Inc.
15.1.1 Business Overview
15.1.2 Product and Service Offerings
15.1.3 Key Financial Summary
15.1.4 Strategic Growth Plans
15.2 NeoGenomics Inc.
15.2.1 Business Overview
15.2.2 Product and Service Offerings
15.2.3 Key Financial Summary
15.2.4 Strategic Growth Plans
15.3 Caris Life Sciences, Inc.
15.3.1 Business Overview
15.3.2 Product and Service Offerings
15.3.3 Strategic Growth Plans
15.4 QIAGEN N.V.
15.4.1 Business Overview
15.4.2 Product and Service Offerings
15.4.3 Key Financial Summary
15.4.4 Strategic Growth Plans
15.5 Helomics Corp.
15.5.1 Business Overview
15.5.2 Product and Service Offerings
15.5.3 Strategic Growth Plans
15.6 Oxford Gene Technology
15.6.1 Business Overview
15.6.2 Product and Service Offerings
15.6.3 Strategic Growth Plans
15.7 HTG Molecular Diagnostics, Inc.
15.7.1 Business Overview
15.7.2 Product and Service Offerings
15.7.3 Key Financial Summary
15.7.4 Strategic Growth Plans
15.8 RiboMed Biotechnologies, Inc.
15.8.1 Business Overview
15.8.2 Product and Service Offerings
15.8.3 Strategic Growth Plans
15.9 Genomic Health, Inc.
15.9.1 Business Overview
15.9.2 Product and Service Offerings
15.9.3 Key Financial Summary
15.9.4 Strategic Growth Plans
15.10 NanoString Technologies, Inc.
15.10.1 Business Overview
15.10.2 Product and Service Offerings
15.10.3 Key Financial Summary
15.10.4 Strategic Growth Plans

Chapter 16. Appendix
16.1 Abbreviations
16.2 Related Report

List of Tables
Table 1 Analysis Period Of The Study
Table 2 Drivers For The Market: Impact Analysis
Table 3 Restraints For The Market: Impact Analysis
Table 4 Global Cancer/Tumor Profiling Market, By Technology, $M (2013 - 2016)
Table 5 Global Cancer/Tumor Profiling Market, By Technology, $M (2017 - 2023)
Table 6 Global Ish Technology Market, By Type, $M (2013 - 2016)
Table 7 Global Ish Technology Market, By Type, $M (2017 - 2023)
Table 8 Global Cancer/Tumor Profiling Market, By Technique, $M (2013 - 2016)
Table 9 Global Cancer/Tumor Profiling Market, By Technique, $M (2017 - 2023)
Table 10 Global Cancer/Tumor Profiling Market, By Application, $M (2013 - 2016)
Table 11 Global Cancer/Tumor Profiling Market, By Application, $M (2017 - 2023)
Table 12 Global Cancer/Tumor Profiling Market, By Region, $M (2013 - 2016)
Table 13 Global Cancer/Tumor Profiling Market, By Region, $M (2017 - 2023)
Table 14 Different Type Of Cancers And The Amount Funded
Table 15 North America Cancer/Tumor Profiling Market, By Technology, $M (2013 - 2016)
Table 16 North America Cancer/Tumor Profiling Market, By Technology, $M (2017 - 2023)
Table 17 North America Cancer/Tumor Profiling Market, By Technique, $M (2013 - 2016)
Table 18 North America Cancer/Tumor Profiling Market, By Technique, $M (2017 - 2023)
Table 19 North America Cancer/Tumor Profiling Market, By Application, $M (2013 - 2016)
Table 20 North America Cancer/Tumor Profiling Market, By Application, $M (2017 - 2023)
Table 21 North America Cancer/Tumor Profiling Market, By Country, $M (2013 - 2016)
Table 22 North America Cancer/Tumor Profiling Market, By Country, $M (2017 - 2023)
Table 23 Europe Cancer/Tumor Profiling Market, By Technology, $M (2013 - 2016)
Table 24 Europe Cancer/Tumor Profiling Market, By Technology, $M (2017 - 2023)
Table 25 Europe Cancer/Tumor Profiling Market, By Technique, $M (2013 - 2016)
Table 26 Europe Cancer/Tumor Profiling Market, By Technique, $M (2017 - 2023)
Table 27 Europe Cancer/Tumor Profiling Market, By Application, $M (2013 - 2016)
Table 28 Europe Cancer/Tumor Profiling Market, By Application, $M (2017 - 2023)
Table 29 Europe Cancer/Tumor Profiling Market, By Country, $M (2013 - 2016)
Table 30 Europe Cancer/Tumor Profiling Market, By Country, $M (2017 - 2023)
Table 31 Asia-Pacific Cancer/Tumor Profiling Market, By Technology, $M (2013 - 2016)
Table 32 Asia-Pacific Cancer/Tumor Profiling Market, By Technology, $M (2017 - 2023)
Table 33 Asia-Pacific Cancer/Tumor Profiling Market, By Technique, $M (2013 - 2016)
Table 34 Asia-Pacific Cancer/Tumor Profiling Market, By Technique, $M (2017 - 2023)
Table 35 Asia-Pacific Cancer/Tumor Profiling Market, By Application, $M (2013 - 2016)
Table 36 Asia-Pacific Cancer/Tumor Profiling Market, By Application, $M (2017 - 2023)
Table 37 Asia-Pacific Cancer/Tumor Profiling Market, By Country, $M (2013 - 2016)
Table 38 Asia-Pacific Cancer/Tumor Profiling Market, By Country, $M (2017 - 2023)
Table 39 Latam Cancer/Tumor Profiling Market, By Technology, $M (2013 - 2016)
Table 40 Latam Cancer/Tumor Profiling Market, By Technology, $M (2017 - 2023)
Table 41 Latam Cancer/Tumor Profiling Market, By Technique, $M (2013 - 2016)
Table 42 Latam Cancer/Tumor Profiling Market, By Technique, $M (2017 - 2023)
Table 43 Latam Cancer/Tumor Profiling Market, By Application, $M (2013 - 2016)
Table 44 Latam Cancer/Tumor Profiling Market, By Application, $M (2017 - 2023)
Table 45 Latam Cancer/Tumor Profiling Market, By Country, $M (2013 - 2016)
Table 46 Latam Cancer/Tumor Profiling Market, By Country, $M (2017 - 2023)
Table 47 Mea Cancer/Tumor Profiling Market, By Technology, $M (2013 - 2016)
Table 48 Mea Cancer/Tumor Profiling Market, By Technology, $M (2017 - 2023)
Table 49 Mea Cancer/Tumor Profiling Market, By Technique, $M (2013 - 2016)
Table 50 Mea Cancer/Tumor Profiling Market, By Technique, $M (2017 - 2023)
Table 51 Mea Cancer/Tumor Profiling Market, By Application, $M (2013 - 2016)
Table 52 Mea Cancer/Tumor Profiling Market, By Application, $M (2017 - 2023)
Table 53 Global Ngs Market, By Region, $M (2013 - 2016)
Table 54 Global Ngs Market, By Region, $M (2017 - 2023)
Table 55 Global Qpcr Market, By Region, $M (2013 - 2016)
Table 56 Global Qpcr Market, By Region, $M (2017 - 2023)
Table 57 Global Ihc Devices Market, By Region, $M (2013 - 2016)
Table 58 Global Ihc Devices Market, By Region, $M (2017 - 2023)
Table 59 Global Ish Market, By Region, $M (2013 - 2016)
Table 60 Global Ish Market, By Region, $M (2017 - 2023)
Table 61 Global Microarray Market, By Region, $M (2013 - 2016)
Table 62 Global Microarray Market, By Region, $M (2017 - 2023)
Table 63 Global Genomics Market, By Region, $M (2013 - 2016)
Table 64 Global Genomics Market, By Region, $M (2017 - 2023)
Table 65 Global Proteomics Market, By Region, $M (2013 - 2016)
Table 66 Global Proteomics Market, By Region, $M (2017 - 2023)
Table 67 Global Epigenetics Devices Market, By Region, $M (2013 - 2016)
Table 68 Global Epigenetics Devices Market, By Region, $M (2017 - 2023)
Table 69 Global Metabolomics Market, By Region, $M (2013 - 2016)
Table 70 Global Metabolomics Market, By Region, $M (2017 - 2023)
Table 71 Global Personalized Medicine Market, By Region, $M (2013 - 2016)
Table 72 Global Personalized Medicine Market, By Region, $M (2017 - 2023)
Table 73 Global Diagnostics Market, By Region, $M (2013 - 2016)
Table 74 Global Diagnostics Market, By Region, $M (2017 - 2023)
Table 75 Global Biomarker Discovery Market, By Region, $M (2013 - 2016)
Table 76 Global Biomarker Discovery Market, By Region, $M (2017 - 2023)
Table 77 Global Prognostics Market, By Region, $M (2013 - 2016)
Table 78 Global Prognostics Market, By Region, $M (2017 - 2023)
Table 79 Illumina, Inc. - at a Glance
Table 80 Illumina, Inc. - Key Financial Summary
Table 81 Neogenomics Inc.- at a Glance
Table 82 Neogenomics Inc. - Key Financial Summary
Table 83 Caris Life Sciences, Inc.- at a Glance
Table 84 Qiagen N.V. - at a Glance
Table 85 Qiagen N.V. - Key Financial Summary
Table 86 Helomics Corp. - at a Glance
Table 87 Oxford Gene Technology - at a Glance
Table 88 Htg Molecular Diagnostics, Inc. -at a Glance
Table 89 Htg Molecular Diagnostics, Inc. - Key Financial Summary
Table 90 Ribomed Biotechnologies, Inc. - at a Glance
Table 91 Genomic Health, Inc. - at a Glance
Table 92 Genomic Health, Inc. - Key Financial Summary
Table 93 Nanostring Technologies, Inc. - at a Glance
Table 94 Nanostring Technologies, Inc., - Key Financial Summary

List of Figures
Fig 1 Research Methodology
Fig 2 Regional Split Of Primary And Secondary Research
Fig 3 Breakdown Of Primary Research By Region
Fig 4 Breakdown Of Primary Research By Industry Participant
Fig 5 Breakdown Of Primary Research By Company Type
Fig 6 Data Triangulation Approach
Fig 7 Global Cancer/Tumor Profiling Market Summary
Fig 8 Porter’S Five Forces Analysis
Fig 9 Global Cancer/Tumor Profiling Market, By Technology, $M (2013 - 2023)
Fig 10 Global Ish Techology Market, By Type, $M (2013 - 2023)
Fig 11 Global Cancer/Tumor Profiling Market, By Technique, $M (2013 - 2023)
Fig 12 Global Cancer/Tumor Profiling Market, By Application, $M (2013 - 2023)
Fig 13 Worldwide Major Markets For Cancer/Tumor Profiling
Fig 14 North America Cancer/Tumor Profiling Market Snapshot
Fig 15 North America Cancer/Tumor Profiling Market, By Technology, $M (2013 - 2023)
Fig 16 North America Cancer/Tumor Profiling Market, By Technique, $M (2013 - 2023)
Fig 17 North America Cancer/Tumor Profiling Market, By Application, $M (2013 - 2023)
Fig 18 North America Cancer/Tumor Profiling Market, By Country, $M (2013 - 2023)
Fig 19 Europe Cancer/Tumor Profiling Market Snapshot
Fig 20 Europe Cancer/Tumor Profiling Market, By Technology, $M (2013 - 2023)
Fig 21 Europe Cancer/Tumor Profiling Market, By Technique, $M (2013 - 2023)
Fig 22 Europe Cancer/Tumor Profiling Market, By Application, $M (2013 - 2023)
Fig 23 Europe Cancer/Tumor Profiling Market, By Country, $M (2013 - 2023)
Fig 24 Asia-Pacific Cancer/Tumor Profiling Market Snapshot
Fig 25 Asia-Pacific Cancer/Tumor Profiling Market, By Technology, $M (2013 - 2023)
Fig 26 Asia-Pacific Cancer/Tumor Profiling Market, By Technique, $M (2013 - 2023)
Fig 27 Asia-Pacific Cancer/Tumor Profiling Market, By Application, $M (2013 - 2023)
Fig 28 Asia-Pacific Cancer/Tumor Profiling Market, By Country, $M (2013 - 2023)
Fig 29 Latam Cancer/Tumor Profiling Market Snapshot
Fig 30 Latam Cancer/Tumor Profiling Market, By Technology, $M (2013 - 2023)
Fig 31 Latam Cancer/Tumor Profiling Market, By Technique, $M (2013 - 2023)
Fig 32 Latam Cancer/Tumor Profiling Market, By Application, $M (2013 - 2023)
Fig 33 Latam Cancer/Tumor Profiling Market, By Country, $M (2013 - 2023)
Fig 34 Mea Cancer/Tumor Profiling Market Snapshot
Fig 35 Mea Cancer/Tumor Profiling Market, By Technology, $M (2013 - 2023)
Fig 36 Mea Cancer/Tumor Profiling Market, By Technique, $M (2013 - 2023)
Fig 37 Mea Cancer/Tumor Profiling Market, By Application, $M (2013 - 2023)
Fig 38 Global Ngs Market, By Region, $M (2013 - 2023)
Fig 39 Global Qpcr Market, By Region, $M (2013 - 2023)
Fig 40 Global Ihc Devices Market, By Region, $M (2013 - 2023)
Fig 41 Global Ish Market, By Region, $M (2013 - 2023)
Fig 42 Global Microarray Market, By Region, $M (2013 - 2023)
Fig 43 Global Genomics Market, By Region, $M (2013 - 2023)
Fig 44 Global Proteomics Market, By Region, $M (2013 - 2023)
Fig 45 Global Epigenetics Devices Market, By Region, $M (2013 - 2023)
Fig 46 Global Metabolomics Market, By Region, $M (2013 - 2023)
Fig 47 Global Personalized Medicine Market, By Region, $M (2013 - 2023)
Fig 48 Global Diagnostics Market, By Region, $M (2013 - 2023)
Fig 49 Global Biomarker Discovery Market, By Region, $M (2013 - 2023)
Fig 50 Global Prognostics Market, By Region, $M (2013 - 2023)
Fig 51 Illumina, Inc. - Revenue Split By Geography (2016)
Fig 52 Neogenomics Inc. - Revenue Split By Segment (2016)
Fig 53 Qiagen N.V. - Revenue Split By Geography (2016)
Fig 54 Htg Molecular Diagnostics, Inc. - Revenue Split By Product (2016)
Fig 55 Htg Molecular Diagnostics, Inc. - Revenue Split By Services (2016)
Fig 56 Genomic Health, Inc. - Revenue Split By Geography (2016)
Fig 57 Nanostring Technologies, Inc. - Revenue Split By Product And Services (2016)
Fig 58 Nanostring Technologies, Inc. - Revenue Split By Geography (2016)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Caris Life Sciences, Inc.
  • Genomic Health, Inc.
  • Helomics Corp.
  • HTG Molecular Diagnostics, Inc.
  • Illumina, Inc.
  • NanoString Technologies, Inc.
  • NeoGenomics Inc.
  • Oxford Gene Technology
  • QIAGEN N.V.
  • RiboMed Biotechnologies, Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll